Dr. Guido Krenning is the Head of Research and an Associate Professor in the Department of Clinical Pharmacy and Pharmacology at the University Medical Center Groningen, University of Groningen. He completed his Ph.D. studies in Medical Sciences at the University of Groningen (2009) and a postdoctoral fellowship at Harvard Medical School (2011). He has published over 60 papers in various journals, and serves as the Chief Scientific Officer of the biotech company Sulfateq and board member of the Dutch Vascular Biology Organization, editorial board member of Scientific Reports and the Journal of Personalized Medicine. His teaching disciplines include, amongst others, Cardiovascular Biology, Biomedical Research, and Scientific Writing. His research interests include chronic cardiovascular, neurodegenerative, and kidney disease, mammalian hibernation, mitochondrial function in health and disease, drug development, systems pharmacology, biomarkers, and personalized medicine.